These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12796530)

  • 1. Gender, cognitive decline, and risk of AD in older persons.
    Barnes LL; Wilson RS; Schneider JA; Bienias JL; Evans DA; Bennett DA
    Neurology; 2003 Jun; 60(11):1777-81. PubMed ID: 12796530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in cognitively stimulating activities and risk of incident Alzheimer disease.
    Wilson RS; Mendes De Leon CF; Barnes LL; Schneider JA; Bienias JL; Evans DA; Bennett DA
    JAMA; 2002 Feb; 287(6):742-8. PubMed ID: 11851541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
    Arvanitakis Z; Wilson RS; Bienias JL; Evans DA; Bennett DA
    Arch Neurol; 2004 May; 61(5):661-6. PubMed ID: 15148141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms, cognitive decline, and risk of AD in older persons.
    Wilson RS; Barnes LL; Mendes de Leon CF; Aggarwal NT; Schneider JS; Bach J; Pilat J; Beckett LA; Arnold SE; Evans DA; Bennett DA
    Neurology; 2002 Aug; 59(3):364-70. PubMed ID: 12177369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
    Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
    Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL
    Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
    Boyle PA; Wilson RS; Aggarwal NT; Tang Y; Bennett DA
    Neurology; 2006 Aug; 67(3):441-5. PubMed ID: 16894105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
    Arvanitakis Z; Schneider JA; Wilson RS; Bienias JL; Kelly JF; Evans DA; Bennett DA
    Neurology; 2008 May; 70(19 Pt 2):1795-802. PubMed ID: 18199831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment in different functional domains and incident Alzheimer's disease.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Bennett DA
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1479-84. PubMed ID: 16227534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Bennett DA
    Arch Neurol; 2006 Dec; 63(12):1763-9. PubMed ID: 17172617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.
    Wilson RS; Schneider JA; Bienias JL; Evans DA; Bennett DA
    Arch Neurol; 2003 Apr; 60(4):539-44. PubMed ID: 12707067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly.
    Buchman AS; Boyle PA; Wilson RS; Tang Y; Bennett DA
    Psychosom Med; 2007 Jun; 69(5):483-9. PubMed ID: 17556640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of mild cognitive impairment in older persons.
    Bennett DA; Wilson RS; Schneider JA; Evans DA; Beckett LA; Aggarwal NT; Barnes LL; Fox JH; Bach J
    Neurology; 2002 Jul; 59(2):198-205. PubMed ID: 12136057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
    Shah RC; Wilson RS; Bienias JL; Arvanitakis Z; Evans DA; Bennett DA
    Neuroepidemiology; 2006; 26(1):30-6. PubMed ID: 16254451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in body mass index and risk of incident Alzheimer disease.
    Buchman AS; Wilson RS; Bienias JL; Shah RC; Evans DA; Bennett DA
    Neurology; 2005 Sep; 65(6):892-7. PubMed ID: 16186530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal decline in cognitive function.
    Wilson RS; Beckett LA; Bienias JL; Evans DA; Bennett DA
    Neurology; 2003 Jun; 60(11):1782-7. PubMed ID: 12796531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the clinical manifestations of Alzheimer disease pathology.
    Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
    Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment.
    Wilson RS; Schneider JA; Arnold SE; Bienias JL; Bennett DA
    Arch Gen Psychiatry; 2007 Oct; 64(10):1204-12. PubMed ID: 17909133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.
    Wilson RS; Schneider JA; Barnes LL; Beckett LA; Aggarwal NT; Cochran EJ; Berry-Kravis E; Bach J; Fox JH; Evans DA; Bennett DA
    Arch Neurol; 2002 Jul; 59(7):1154-60. PubMed ID: 12117364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
    Jones S; Small BJ; Fratiglioni L; Backman L
    Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.